Logo
Pharmavoice in industry opinions.
Thumbnail image
thumbnail

Advances in risk assessment shift the calculus of early intervention trials for MASLD

Discover how evolving risk assessment strategies are helping sponsors optimise early intervention trials in MASLD. Read the full article.